BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15294947)

  • 1. TIRC7 deficiency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response.
    Utku N; Boerner A; Tomschegg A; Bennai-Sanfourche F; Bulwin GC; Heinemann T; Loehler J; Blumberg RS; Volk HD
    J Immunol; 2004 Aug; 173(4):2342-52. PubMed ID: 15294947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody specific for TIRC7 induces donor-specific anergy and prevents rejection of cardiac allografts in mice.
    Kumamoto Y; Tomschegg A; Bennai-Sanfourche F; Boerner A; Kaser A; Schmidt-Knosalla I; Heinemann T; Schlawinsky M; Blumberg RS; Volk HD; Utku N
    Am J Transplant; 2004 Apr; 4(4):505-14. PubMed ID: 15023142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.
    Bulwin GC; Heinemann T; Bugge V; Winter M; Lohan A; Schlawinsky M; Schulze A; Wälter S; Sabat R; Schülein R; Wiesner B; Veh RW; Löhler J; Blumberg RS; Volk HD; Utku N
    J Immunol; 2006 Nov; 177(10):6833-41. PubMed ID: 17082597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
    Frischer JM; Reindl M; Künz B; Berger T; Schmidt S; Milford EL; Knosp E; Lassmann H; Utku N
    Mult Scler; 2014 Aug; 20(9):1171-81. PubMed ID: 24526664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIRC7 pathway as a target for preventing allograft rejection.
    Tamura A; Milford EL; Utku N
    Drug News Perspect; 2005 Mar; 18(2):103-8. PubMed ID: 15883619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell immune response cDNA 7 in allograft rejection and inflammation.
    Utku N; Heinemann T; Milford EL
    Curr Opin Investig Drugs; 2007 May; 8(5):401-10. PubMed ID: 17520869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody targeting of TIRC7 results in significant therapeutic effects on collagen-induced arthritis in mice.
    Utku N; Heinemann T; Winter M; Bulwin CG; Schlawinsky M; Fraser P; Nieuwenhuis EE; Volk HD; Blumberg RS
    Clin Exp Immunol; 2006 Apr; 144(1):142-51. PubMed ID: 16542376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein.
    Utku N; Heinemann T; Tullius SG; Bulwin GC; Beinke S; Blumberg RS; Beato F; Randall J; Kojima R; Busconi L; Robertson ES; Schülein R; Volk HD; Milford EL; Gullans SR
    Immunity; 1998 Oct; 9(4):509-18. PubMed ID: 9806637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of IL-10-secreting T cells derived from regulatory CD4+CD25+ cells by the TIRC7 surface marker.
    Wakkach A; Augier S; Breittmayer JP; Blin-Wakkach C; Carle GF
    J Immunol; 2008 May; 180(9):6054-63. PubMed ID: 18424726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin is a negative regulator of antigen-activated T cells.
    Wilk S; Scheibenbogen C; Bauer S; Jenke A; Rother M; Guerreiro M; Kudernatsch R; Goerner N; Poller W; Elligsen-Merkel D; Utku N; Magrane J; Volk HD; Skurk C
    Eur J Immunol; 2011 Aug; 41(8):2323-32. PubMed ID: 21538348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
    Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic organization of the gene coding for TIRC7, a novel membrane protein essential for T cell activation.
    Heinemann T; Bulwin GC; Randall J; Schnieders B; Sandhoff K; Volk HD; Milford E; Gullans SR; Utku N
    Genomics; 1999 May; 57(3):398-406. PubMed ID: 10329006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease.
    Zhu F; Qiu T; Zhu S; Zhao K; Chen C; Qiao J; Pan B; Yan Z; Chen W; Liu Q; Wu Q; Cao J; Sang W; Zeng L; Sun H; Li Z; Xu K
    Oncol Rep; 2020 Jul; 44(1):43-54. PubMed ID: 32319655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of T cell immune response cDNA 7 in patients with acute graft-versus-host disease.
    Zhu F; Qiao J; Chen W; Pan B; Wu QY; Cao J; Sang W; Yan ZL; Zeng LY; Li ZY; Xu KL
    Ann Hematol; 2015 Jun; 94(6):1025-32. PubMed ID: 25623380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of intragraft and peripheral blood TIRC7 expression as a diagnostic tool for acute cardiac rejection in humans.
    Shulzhenko N; Morgun A; Rampim GF; Franco M; Almeida DR; Diniz RV; Carvalho AC; Gerbase-DeLima M
    Hum Immunol; 2001 Apr; 62(4):342-7. PubMed ID: 11295466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIRC7 is induced in rejected human kidneys and anti-TIRC7 mAb with FK506 prolongs survival of kidney allografts in rats.
    Kumamoto Y; Tamura A; Volk HD; Reinke P; Löhler J; Tullius SG; Utku N
    Transpl Immunol; 2006 Nov; 16(3-4):238-44. PubMed ID: 17138060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP).
    Zhu F; Qiao J; Cao J; Sun HY; Wu QY; Sun ZT; Zhao K; Sang W; Qi KM; Zeng LY; Li ZY; Xu KL
    Thromb Res; 2015 Oct; 136(4):797-802. PubMed ID: 26272303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative study of hypothalamus-pituitary-thyroid-immune system interaction: thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway.
    Klecha AJ; Genaro AM; Gorelik G; Barreiro Arcos ML; Silberman DM; Schuman M; Garcia SI; Pirola C; Cremaschi GA
    J Endocrinol; 2006 Apr; 189(1):45-55. PubMed ID: 16614380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD180 (RP105) activates B cells to rapidly produce polyclonal Ig via a T cell and MyD88-independent pathway.
    Chaplin JW; Kasahara S; Clark EA; Ledbetter JA
    J Immunol; 2011 Oct; 187(8):4199-209. PubMed ID: 21918197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR alpha 2 mediates negative signalling via binding to Tirc7 leading to anti-inflammatory and apoptotic effects in lymphocytes in vitro and in vivo.
    Bulwin GC; Wälter S; Schlawinsky M; Heinemann T; Schulze A; Höhne W; Krause G; Kalka-Moll W; Fraser P; Volk HD; Löhler J; Milford EL; Utku N
    PLoS One; 2008 Feb; 3(2):e1576. PubMed ID: 18270567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.